A securities class action has been filed against Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS) and certain executive officers on behalf of investors who purchased or otherwise acquired Hims & Hers securities between August 4, 2025 and July 29, 2026, inclusive (the “Class Period”).

The action, Velanki v. Hims & Hers Health, Inc., et al., Case No. 5:26-cv-09313-EKL, was filed on September 1, 2026 in the U.S. District Court for the Northern District of California. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.

If you acquired Hims & Hers securities during the Class Period and suffered a financial loss, contact Kehoe Law Firm to discuss your legal rights without cost or obligation.

What Does the Hims & Hers Health Securities Class Action Allege?

The complaint alleges that Hims & Hers made materially false and/or misleading statements and failed to disclose material adverse facts concerning the Company’s business, operations, and prospects.

Specifically, the complaint alleges that Hims & Hers shared consumers’ health information with third-party advertising platforms and charged consumers for prescriptions almost immediately after they submitted an intake form, despite telling consumers that they would be able to consult with a medical provider to find a treatment that was “right for them.”

The complaint further alleges that this conduct subjected the Company to regulatory scrutiny and made Hims & Hers reasonably likely to incur fees and penalties. As a result, the complaint alleges that defendants’ positive statements about Him & Hers’ business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

The July 29, 2026 FTC Lawsuit and HIMS Stock Decline

According to the complaint, on July 29, 2026, during market hours, the Federal Trade Commission announced that it had filed a lawsuit against Hims & Hers alleging that the telehealth provider shared consumers’ sensitive health information with third-party advertising platforms, despite claiming that its services maintained consumers’ privacy, and deceived users about its billing and cancellation practices.

The complaint further alleges that, on this news, Hims & Hers shares declined $4.32, or 14.73%, to close at $25.00 on July 29, 2026, on unusually heavy trading volume.

NOTE: This action is distinct from the earlier Hims & Hers securities litigation, which involves allegations concerning the Company’s relationship with Novo Nordisk and was consolidated as In re Hims & Hers Health, Inc. Securities Litigation, No. 25-cv-05315.

November 2, 2026 Lead Plaintiff Deadline: Investors who wish to seek appointment as lead plaintiff must do so by November 2, 2026. Investors do not need to seek appointment as lead plaintiff to remain potential members of the proposed class.

Hims & Hers Health Investors: Contact Kehoe Law Firm

Investors who purchased or otherwise acquired Hims & Hers securities during the Class Period and suffered financial losses are encouraged to complete Kehoe Law Firm’s confidential Stockholder Information Request Form or send us a message to discuss their legal rights.

For a free, no-obligation legal evaluation, contact:

Michael Yarnoff, Esq.
(215) 792-6676, Ext. 804
[email protected]
[email protected]

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action law firm representing investors, consumers, and employees in matters involving securities fraud, corporate misconduct, mergers and acquisitions, antitrust violations, whistleblower claims, data breaches, consumer fraud, employment law violations, and retirement-plan mismanagement. Its attorneys have served as lead or co-lead counsel in major securities cases, recovering more than $10 billion for institutional and individual investors.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning plaintiffs are not responsible for attorneys’ fees or litigation expenses. Any request for attorneys’ fees and expenses will be subject to court approval.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

A securities class action has been filed against York Space Systems Inc. (“York” or the “Company”) (NYSE: YSS) and certain officers and other defendants on behalf of investors who purchased or otherwise acquired: (a) York common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s January 2026 initial public offering; and/or (b) York securities between January 29, 2026 and May 11, 2026, inclusive (the “Class Period”).

The action, Ianelli v. York Space Systems Inc., et al., Case No. 1:26-cv-04074, was filed on August 31, 2026 in the U.S. District Court for the District of Colorado. The complaint asserts claims under Sections 11 and 15 of the Securities Act of 1933 and Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.

If you acquired York securities in connection with the IPO or during the Class Period and suffered a financial loss, contact Kehoe Law Firm to discuss your legal rights without cost or obligation.

What Does the York Space Systems Securities Class Action Allege?

The complaint alleges that York’s registration statement and certain public statements were materially false and/or misleading and failed to disclose material adverse information concerning the Company’s business, operations, and prospects. Specifically, the complaint alleges that defendants failed to disclose that:

• York’s onboard mission and payload software was not fully functional before satellites were launched;
• This alleged ongoing trend presented a risk to York’s contracts with the U.S. Space Development Agency (“SDA”); and
• As a result, defendants’ positive statements about York’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

The May 11, 2026 Report and YSS Stock Decline

According to the complaint, on May 11, 2026, Wolfpack Research published a report citing former employees who claimed, among other things, that York launched satellites before mission-critical software was fully developed. Wolfpack Research also suspected that the Pentagon’s decision to halt Tranche 3 funding may have been related to York’s alleged software and performance issues.

The complaint alleges that, on this news, YSS stock fell approximately $7 during intraday trading on May 11, 2026, on unusually heavy trading volume. By the commencement of the action, York’s stock was trading as low as $9.33 per share, more than 70% below the $34.00 per-share IPO price.

Review the York Space Systems Securities Class Action Complaint

York Space Systems Investors: Contact Kehoe Law Firm

Investors who acquired York common stock in connection with the January 2026 IPO and/or York securities during the Class Period and suffered financial losses are encouraged to complete Kehoe Law Firm’s confidential Stockholder Information Request Form or send us a message to discuss their legal rights.

For a free, no-obligation legal evaluation, contact:

Michael Yarnoff, Esq.
(215) 792-6676, Ext. 804
[email protected]
[email protected]

Lead Plaintiff Deadline: October 30, 2026. Investors who wish to seek appointment as lead plaintiff must do so by October 30, 2026. Investors do not need to seek appointment as lead plaintiff to remain potential members of the proposed class or to be eligible to share in any potential recovery.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action law firm representing investors, consumers, and employees in matters involving securities fraud, corporate misconduct, mergers and acquisitions, antitrust violations, whistleblower claims, data breaches, consumer fraud, employment law violations, and retirement-plan mismanagement. Its attorneys have served as lead or co-lead counsel in major securities cases, recovering more than $10 billion for institutional and individual investors.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning plaintiffs are not responsible for attorneys’ fees or litigation expenses. Any request for attorneys’ fees and expenses will be subject to court approval.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

A securities class action has been filed against XTI Aerospace, Inc. (“XTI Aerospace” or the “Company”) (NASDAQ: XTIA) and certain of its officers on behalf of investors who purchased or otherwise acquired XTI Aerospace securities between April 15, 2026 and August 17, 2026, inclusive (the “Class Period”).

The action, Noalan v. XTI Aerospace, Inc. et al., Case No. 1:26-cv-07378, was filed on August 28, 2026 in the U.S. District Court for the Southern District of New York. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b-5.

If you acquired XTI Aerospace securities during the Class Period and suffered a financial loss, contact Kehoe Law Firm to discuss your legal rights without cost or obligation.

What Does the XTI Aerospace Securities Class Action Allege?

The complaint focuses on XTI Aerospace’s April 15 and May 14, 2026 public statements and SEC filings, including its Form 10-K and Form 10-Q. Among other things, those filings stated that the Company’s disclosure controls and procedures were effective. The complaint alleges that these and other positive statements were materially false and/or misleading because defendants failed to disclose material adverse information to investors, including that:

• Senior executives had engaged in certain undisclosed activities;
• Those activities required Board review;
• There was reason to doubt the effectiveness of the Company’s disclosure controls and procedures;
• As a result, the Company would be unable to timely file its earnings reports; and
• As a result of the foregoing, defendants’ positive statements about XTI Aerospace’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

The Internal Review and Form 10-Q Delay

According to the complaint, on August 17, 2026, after the market closed, XTI Aerospace disclosed that it was unable to timely file its Form 10-Q for the quarter ended June 30, 2026 because it was completing an internal review of its former Chief Executive Officer, who resigned that day, and other related corporate governance matters.

The Company stated that the review was being conducted entirely by a committee of independent directors represented by independent counsel, that a timeline for completion had not yet been determined, and that it was evaluating the implications of the review for disclosures, certifications, controls, and governance matters. XTI Aerospace also stated that at that time, it did not believe the matters under review would affect previously issued financial statements.

The complaint alleges that, on this news, XTI Aerospace’s stock price fell $0.25 per share, or 15.9%, to close at $1.32 per share on August 18, 2026, on unusually heavy trading volume.

Review the XTI Aerospace Securities Class Action Complaint

XTI Aerospace Investors: Contact Kehoe Law Firm

Investors who purchased or otherwise acquired XTI Aerospace securities during the Class Period and suffered financial losses are encouraged to complete Kehoe Law Firm’s confidential Stockholder Information Request Form or send us a message to discuss their legal rights.

For a free, no-obligation legal evaluation, contact:

Michael Yarnoff, Esq.
(215) 792-6676, Ext. 804
[email protected]
[email protected]

Lead Plaintiff Deadline: October 27, 2026. Investors who wish to seek appointment as lead plaintiff must do so by October 27, 2026. Investors do not need to seek appointment as lead plaintiff to remain potential members of the proposed class or to be eligible to share in any potential recovery.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action law firm representing investors, consumers, and employees in matters involving securities fraud, corporate misconduct, mergers and acquisitions, antitrust violations, whistleblower claims, data breaches, consumer fraud, employment law violations, and retirement-plan mismanagement. Its attorneys have served as lead or co-lead counsel in major securities cases, recovering more than $10 billion for institutional and individual investors.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning plaintiffs are not responsible for attorneys’ fees or litigation expenses. Any request for attorneys’ fees and expenses will be subject to court approval.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

A securities class action has been filed against Hyliion Holdings Corp. (“Hyliion” or the “Company”) (NYSE American: HYLN) and certain of its officers on behalf of investors who purchased or otherwise acquired Hyliion common stock between May 12, 2026 and June 23, 2026, inclusive (the “Class Period”).

The action, Olmeta v. Hyliion Holdings Corp. et al., Case No. 1:26-cv-02375, was filed on August 28, 2026 in the U.S. District Court for the Western District of Texas. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b-5.

If you acquired Hyliion common stock during the Class Period and suffered a financial loss, contact Kehoe Law Firm to discuss your legal rights without cost or obligation.

What Does the Hyliion Securities Class Action Allege?

The complaint concerns Hyliion’s statements about its commercial pipeline and a non-binding letter of intent with VFG Holdings, LLC (“VFG”) involving the potential deployment of up to 250 KARNO Cores over five years.

The complaint alleges that defendants made materially false and/or misleading statements and omitted material information concerning the credibility and commercial viability of the VFG partnership, including the basis for management’s confidence in VFG and the extent of Hyliion’s evaluation of VFG’s operational capabilities, financial resources, development experience, and ability to perform.

The VFG Partnership and Pelican Way Research Report

According to the complaint, Hyliion announced on May 12, 2026 that it and VFG had entered into a non-binding letter of intent establishing a strategic partnership focused on deploying KARNO Power Modules for next-generation data center applications. The proposed deployments represented approximately $133 million in potential revenue and roughly one-third of Hyliion’s more than $400 million in disclosed potential revenue from non-binding letters of intent.

According to the complaint, on June 23, 2026, Pelican Way Research published a report questioning the credibility of Hyliion’s commercial pipeline, particularly the VFG letter of intent. The report alleged that VFG was recently formed, appeared to have limited staffing, and lacked publicly available evidence of the operational and financial capacity to support the proposed $133 million opportunity.

According to the complaint, Hyliion’s stock price fell from $7.37 per share on June 22, 2026 to $6.10 per share on June 23, 2026, a decline of approximately 17%. The stock price then fell another $1.18 per share, or approximately 19%, to close at $4.92 per share on June 24, 2026.

Review the Hyliion Securities Class Action Complaint

Olmeta v. Hyliion Holdings Corp. et al., Case No. 1:26-cv-02375 — Class Action Complaint

Note: A separate securities class action, Draftz v. Hyliion Holdings Corp. et al., Case No. 1:26-cv-02369, was also filed in the U.S. District Court for the Western District of Texas on August 28, 2026.

Hyliion Investors: Contact Kehoe Law Firm

Investors who purchased or otherwise acquired Hyliion securities during the Class Period and suffered financial losses are encouraged to complete Kehoe Law Firm’s confidential Stockholder Information Request Form or send us a message to discuss their legal rights.

For a free, no-obligation legal evaluation, contact:

Michael Yarnoff, Esq.
(215) 792-6676, Ext. 804
[email protected]
[email protected]

Lead Plaintiff Deadline: October 27, 2026. Investors who wish to seek appointment as lead plaintiff must do so by October 27, 2026. Investors do not need to seek appointment as lead plaintiff to remain potential members of the proposed class or to be eligible to share in any potential recovery.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action law firm representing investors, consumers, and employees in matters involving securities fraud, corporate misconduct, mergers and acquisitions, antitrust violations, whistleblower claims, data breaches, consumer fraud, employment law violations, and retirement-plan mismanagement. Its attorneys have served as lead or co-lead counsel in major securities cases, recovering more than $10 billion for institutional and individual investors.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning plaintiffs are not responsible for attorneys’ fees or litigation expenses. Any request for attorneys’ fees and expenses will be subject to court approval.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]